Times Online
Our Homes Today
Rural Living
Home
News
Blogs
Features
Awards
About Us
e-newsletter
Directory
A word from the editor's desk
Ten questions in ten minutes
As We See It
Dining
Getting the Message Across
Internet Stuff
Investment Clues
Legal Focus
The Business Maverick
Held in Trust
The IT Report
Spotlight
My business my way
Archives
Southern Focus
Northern Focus
Western Focus
Business Expo
Business Branding & Gifts
Business Technology
Design, Print & Packaging
Training & Education
Pride In Print
Politics
Meetings & Conferences
Chill Out
Bucking The Trend
Entrepreneurial Expose
Human Resources
Westpac Waitakere Business Awards
Westpac Manukau Business Excellence Awards
Westpac Enterprise North Shore Business Awards
Vero Excellence In Business Support Awards
Air New Zealand Auckland Export Awards
Best of the Best
EEO Trust Awards
Franchise Awards
Other Awards
Contact Us
Accounting & Legal
Design
Commercial Property
Dining & Catering
Motoring
Meetings & Conferences
Print & Packaging
Training & Education
Retail
IT/Web
Manufacturing
Recruitment
Business Services
Trade Services
Lifestyle
News Headlines
Manukau Business Awards - a benchmarking opportunity
OCR unchanged at 2.5 percent
Business success tips for students
Cruise Control
Appointments
Microsoft NZ teams up with The Apprentice NZ
Wholesale funding guarantee to end
BNI recognises social responsibility
Robert Half tops Fortune magazine's list
Importance of planning
News
Scientist-author to head R&D at Manuka Health NZ
Thursday, 04 February 2010
Food scientist and author Dr Lynne Chepulis has been appointed Research and Development Manager at honey health science company Manuka Health New Zealand Ltd.
Dr Lynne Chepulis with her book.
Announcing the appointment, Chief Executive Kerry Paul said Manuka Health is expanding R&D to advance its position in the $100 million manuka honey export industry.
“We need more in-house capability to exploit scientific advances in the uses for bee products,” he said. “Dr Chepulis is the ideal person to lead that.”
Manuka Health is the only company to certify the level of the active ingredient methylglyoxal responsible for the antibacterial activity of its MGO™ manuka honey products. It also markets non-honey bee products such as Bio30™ propolis which international researchers are investigating for its cancer-blocking properties.
Dr Chepulis returns from New Zealand from Australia’s Griffith University where she was a nutrition lecturer. She has previous experience as a Crop and Food scientist and at Dexcel.
Her Phd at the University of Waikato’s honey research unit was a joint project with Fonterra to investigate the health advantages of honey over other sugars.
She is the author of a book “Healing Honey: A Natural Remedy for Health and Wellness” and numerous peer-reviewed publications.
Dr Chepulis will be based at Manuka Health’s Te Awamutu processing centre.
